COST AND HEALTHCARE RESOURCE UTILIZATION (HRU) RESULTING FROM IMMUNE-RELATED ADVERSE EVENTS (IRAES) AMONG PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICIS)

被引：0
|
作者：
Zheng, Y. [1 ]
Kim, R. [2 ]
Yu, T. [1 ]
Dreyfus, J. [3 ]
Gayle, J. A. [3 ]
Wassel, C. L. [3 ]
Phatak, H. [1 ]
George, S. [4 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
[2] Pfizer Inc, New York, NY USA
[3] Premier Inc, Charlotte, NC USA
[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN171
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [41] Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).
    Riudavets, Mariona
    Barba, Andres
    Maroto, Pablo
    Sullivan, Ivana Gabriela
    Anguera, Georgia
    Paez, David
    del Carpio, Luis
    Callejo, Ana
    Gonzalez Blanco, Cintia
    Garcia Planellas, Esther
    Castillo, Diego
    Facundo, Carme
    Genua, Idoia
    Martin Lorente, Cristina
    Virgili, Ana
    Sebio, Ana
    Gallego, Oscar
    Lopez-Pousa, Antonio
    Barnadas, Agust
    Majem, Margarita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
    Barron, Carly C.
    Stefanova, Isabella
    Cha, Yevin
    Elsolh, Karam
    Zereshkian, Arman
    Gaafour, Nessma
    McWhirter, Elaine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [43] Immune-related adverse events (irAE) in GU cancer patients receiving immune checkpoint inhibitors.
    Zang, Peter
    Drakaki, Alexandra
    Faiena, Izak
    Chan, Betty
    Tsao-Wei, Denice
    Groshen, Susan G.
    Quinn, David I.
    Dorff, Tanya B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [44] In the Clinic Immune-Related Adverse Events of Immune Checkpoint Inhibitors
    Ramos-Casals, Manuel
    Siso-Almirall, Antoni
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (02) : ITC17 - ITC32
  • [45] Immune-related adverse events of immune checkpoint inhibitors: a review
    Yin, Qinan
    Wu, Liuyun
    Han, Lizhu
    Zheng, Xingyue
    Tong, Rongsheng
    Li, Lian
    Bai, Lan
    Bian, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
  • [47] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Daphne Day
    Aaron R. Hansen
    BioDrugs, 2016, 30 : 571 - 584
  • [48] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Day, Daphne
    Hansen, Aaron R.
    BIODRUGS, 2016, 30 (06) : 571 - 584
  • [49] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [50] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN SPANISH PATIENTS
    Villalobos, L.
    Giraldo-sifuentes, W. A.
    Moran-alvarez, P.
    Arroyo Palomo, J.
    Briones-figueroa, A.
    Rita, C.
    Morell-hita, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 511 - 511
12345